Company intelligence / Profile preview

Vively

Sydney, New South Wales, Australiavively.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vively offers a digital platform that enables users to track their metabolic responses to food and exercise in real time. The company leverages continuous glucose monitoring and data analytics to provide personalized recommendations for improving metabolic health. It is positioned as a tool for people with chronic conditions or those seeking better overall wellness through lifestyle medicine. No clinical trial results are published; the product is commercially available.

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Non-pharmacological therapyDigital health intervention (focus on lifestyle and metabolic tracking)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Vively.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vively.

Explore the full profile